How fructose affects liver cell function and inflammation
Fructose Induced Regulation of Profibrogenic Factors in Hepatic Nonparenchymal Cells
This study is looking at how eating a lot of fructose affects liver health, especially in people with nonalcoholic fatty liver disease (NAFLD), and it aims to find out how fructose changes certain liver cells to help us understand and possibly treat this condition better.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | North Carolina State University Raleigh NIH-funded |
| Lab location | 1 site (Raleigh, United States) |
| Project ID | NIH-10689986 on NIH RePORTER |
What this research studies
This research investigates the impact of high fructose consumption on liver health, particularly focusing on nonparenchymal cells that contribute to liver inflammation and fibrosis. It aims to uncover the metabolic pathways influenced by fructose that lead to nonalcoholic fatty liver disease (NAFLD). By studying how fructose alters the behavior of specific liver cells, the research seeks to identify new mechanisms that could help in understanding and potentially treating NAFLD. Patients may be involved in providing samples or data to help elucidate these effects.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults who consume high amounts of fructose and may be experiencing symptoms related to nonalcoholic fatty liver disease.
Not a fit: Patients who do not consume fructose or have no liver-related health issues may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new insights and treatments for nonalcoholic fatty liver disease, improving liver health for many patients.
How similar studies have performed: Previous research has shown that dietary components like fructose can significantly impact liver health, suggesting that this investigation is building on established findings.
Where this research is happening
Raleigh, United States
- North Carolina State University Raleigh — Raleigh, United States (Active)
Researchers
- Principal investigator: Kennedy, Arion — North Carolina State University Raleigh
- Study coordinator: Kennedy, Arion
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.